Afuco™ Anti-Human CD40 ADCC Therapeutic Antibody (APX005), ADCC Enhanced
Anti-CD40 ADCC Enhanced Antibody (APX005) is an ADCC enhanced antibody produced by our Afuco™ platform. APX005 is a promising immunotherapeutic capable of destroying tumor and tumor stroma through several distinct mechanisms of action. APX005 is a strong CD40 agonist that can stimulate anti-tumor immune responses by binding to CD40 molecules on the antigen presenting cells and activating immune co-stimulatory pathways to boost tumor-specific immunity. Furthermore, APX005 can also trigger direct tumor killing.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-120CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CD40 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Can be stored at 4°C. For long term storage, aliquot and store at -20°C. Avoid repeated freezing and thawing cycles. |